{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:11:31Z","timestamp":1768709491533,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11596-015-1496-0","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T04:11:40Z","timestamp":1445487100000},"page":"716-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats"],"prefix":"10.1007","volume":"35","author":[{"given":"Jing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"issue":"2","key":"1496_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","volume":"16","author":"JW Sander","year":"2003","unstructured":"Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol, 2003,16(2):165\u2013170","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"1496_CR2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1474-4422(08)70108-X","volume":"7","author":"SU Schuele","year":"2008","unstructured":"Schuele SU, Luders HO. Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol, 2008,7 (6):514\u2013524","journal-title":"Lancet Neurol"},{"issue":"2","key":"1496_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00436-O","volume":"286","author":"M Noyer","year":"1995","unstructured":"Noyer M, Gillard M, Matagne A, et al. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol, 1995,286(2):137\u2013146","journal-title":"Eur J Pharmacol"},{"issue":"26","key":"1496_CR4","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","volume":"96","author":"KM Crowder","year":"1999","unstructured":"Crowder KM, Gunther JM, Jones TA, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A, 1999,96(26): 15268\u201315273","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1496_CR5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0896-6273(00)81046-6","volume":"24","author":"R Janz","year":"1999","unstructured":"Janz R, Goda Y, Geppert M, et al. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron, 1999,24(4):1003\u20131016","journal-title":"Neuron"},{"issue":"3","key":"1496_CR6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1528-1167.2008.01727.x","volume":"50","author":"EA Vliet van","year":"2009","unstructured":"van Vliet EA, Aronica E, Redeker S, et al. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia, 2009,50(3):422\u2013433","journal-title":"Epilepsia"},{"issue":"3","key":"1496_CR7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12031-009-9288-2","volume":"39","author":"G Feng","year":"2009","unstructured":"Feng G, Xiao F, Lu Y, et al. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. J Mol Neurosci, 2009,39(3):354\u2013359","journal-title":"J Mol Neurosci"},{"issue":"11","key":"1496_CR8","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","volume":"66","author":"TA Glauser","year":"2006","unstructured":"Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology, 2006,66(11):1654\u20131660","journal-title":"Neurology"},{"issue":"1","key":"1496_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.seizure.2004.02.006","volume":"14","author":"R Mohanraj","year":"2005","unstructured":"Mohanraj R, Parker PG, Stephen LJ, et al. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure, 2005,14(1):23\u201327","journal-title":"Seizure"},{"issue":"12","key":"1496_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","volume":"47","author":"J French","year":"2001","unstructured":"French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res, 2001,47(12):77\u201390","journal-title":"Epilepsy Res"},{"issue":"4","key":"1496_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.seizure.2007.02.004","volume":"16","author":"S Grosso","year":"2007","unstructured":"Grosso S, Cordelli DM, Franzoni E, et al. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure, 2007,16(4):345\u2013350","journal-title":"Seizure"},{"issue":"7","key":"1496_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.seizure.2005.08.002","volume":"14","author":"J Opp","year":"2005","unstructured":"Opp J, Tuxhorn I, May T, et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure, 2005,14(7):476\u2013484","journal-title":"Seizure"},{"issue":"26","key":"1496_CR13","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA, 2004,101 (26):9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"1496_CR14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2006.02.022","volume":"536","author":"M Gillard","year":"2006","unstructured":"Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol, 2006,536(1\u20132):102\u2013108","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"1496_CR15","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1517\/14656566.2011.591380","volume":"12","author":"A Schulze-Bonhage","year":"2011","unstructured":"Schulze-Bonhage A. Brivaracetam for the treatment of epilepsy. Expert Opin Pharmacother, 2011,12(12):1959\u20131966","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1496_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nurt.2006.11.014","volume":"4","author":"B Bennett","year":"2007","unstructured":"Bennett B, Matagne A, Michel P, et al. Seletracetam (UCB 44212). Neurotherapeutics, 2007,4(1):117\u2013122","journal-title":"Neurotherapeutics"},{"issue":"1","key":"1496_CR17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nurt.2006.11.004","volume":"4","author":"P Rosenstiel von","year":"2007","unstructured":"von Rosenstiel P. Brivaracetam (UCB 34714). Neurotherapeutics, 2007,4(1):84\u201387","journal-title":"Neurotherapeutics"},{"issue":"9","key":"1496_CR18","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","volume":"14","author":"SM Bajjalieh","year":"1994","unstructured":"Bajjalieh SM, Frantz GD, Weimann JM, et al. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci, 1994,14(9):5223\u20135235","journal-title":"J Neurosci"},{"issue":"4","key":"1496_CR19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0306-4522(99)00370-X","volume":"94","author":"R Janz","year":"1999","unstructured":"Janz R, Sudhof TC. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience, 1999,94(4): 1279\u20131290","journal-title":"Neuroscience"},{"issue":"6","key":"1496_CR20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1528-1167.2008.01955.x","volume":"50","author":"ST Toering","year":"2009","unstructured":"Toering ST, Boer K, de Groot M, et al. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia, 2009,50(6): 1409\u20131418","journal-title":"Epilepsia"},{"issue":"2","key":"1496_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1525-1403.2012.00493.x","volume":"16","author":"G Wu","year":"2012","unstructured":"Wu G, Hong Z, Li Y, et al. Effects of low-frequency hippocampal stimulation on gamma-amino butyric acid type B receptor expression in pharmacoresistant amygdaloid kindling epileptic rats. Neuromodulation, 2012,16(2):105\u2013113","journal-title":"Neuromodulation"},{"issue":"6","key":"1496_CR22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0361-9230(81)90109-X","volume":"7","author":"FG Freeman","year":"1981","unstructured":"Freeman FG, Jarvis MF. The effect of interstimulation interval on the assessment and stability of kindled seizure thresholds. Brain Res Bull, 1981,7(6):629\u2013633","journal-title":"Brain Res Bull"},{"issue":"2\u20133","key":"1496_CR23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eplepsyres.2004.02.005","volume":"59","author":"ML Lopez-Meraz","year":"2004","unstructured":"Lopez-Meraz ML, Neri-Bazan L, Rocha L. Low frequency stimulation modifies receptor binding in rat brain. Epilepsy Res, 2004,59(2\u20133):95\u2013105","journal-title":"Epilepsy Res"},{"issue":"3","key":"1496_CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0013-4694(72)90178-2","volume":"32","author":"R Racine","year":"1972","unstructured":"Racine R, Okujava V, Chipashvili S. Modification of seizure activity by electrical stimulation. 3. Mechanisms. Electroencephalogr Clin Neurophysiol, 1972,32(3):295\u2013299","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"1496_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroscience.2012.05.009","volume":"217","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Wu ZC, Yu JT, et al. Mode-dependent effect of high-frequency electrical stimulation of the anterior thalamic nucleus on amygdala-kindled seizures in rats. Neuroscience, 2012,217:113\u2013122","journal-title":"Neuroscience"},{"issue":"1","key":"1496_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(00)00108-X","volume":"40","author":"W Loscher","year":"2000","unstructured":"Loscher W, Reissmuller E, Ebert U. Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoinresistant kindled rats. Epilepsy Res, 2000,40(1):63\u201377","journal-title":"Epilepsy Res"},{"issue":"1","key":"1496_CR27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","volume":"24","author":"C Brandt","year":"2006","unstructured":"Brandt C, Bethmann K, Gastens AM, et al. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis, 2006,24(1):202\u2013211","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1496_CR28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1083\/jcb.100.4.1284","volume":"100","author":"K Buckley","year":"1985","unstructured":"Buckley K, Kelly RB. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J Cell Biol, 1985,100(4):1284\u20131294","journal-title":"J Cell Biol"},{"issue":"8","key":"1496_CR29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/35087000","volume":"3","author":"T Xu","year":"2001","unstructured":"Xu T, Bajjalieh SM. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat Cell Biol, 2001,3(8):691\u2013698","journal-title":"Nat Cell Biol"},{"issue":"3","key":"1496_CR30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1152\/jn.00279.2011","volume":"106","author":"AL Meehan","year":"2011","unstructured":"Meehan AL, Yang X, Mc Adams BD, et al. A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam. J Neurophysiol, 2011,106(3):1227\u20131239","journal-title":"J Neurophysiol"},{"issue":"4","key":"1496_CR31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2007.11.021","volume":"54","author":"RM Kaminski","year":"2008","unstructured":"Kaminski RM, Matagne A, Leclercq K, et al. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology, 2008,54(4):715\u2013720","journal-title":"Neuropharmacology"},{"issue":"7","key":"1496_CR32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1528-1167.2007.01516.x","volume":"49","author":"EA Vliet van","year":"2008","unstructured":"van Vliet EA, van Schaik R, Edelbroek PM, et al. Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia, 2008,49(7):1151\u20131159","journal-title":"Epilepsia"},{"issue":"2","key":"1496_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1535-7511.2009.01351.x","volume":"10","author":"GJ Sills","year":"2010","unstructured":"Sills GJ. SV2A in epilepsy: the plot thickens. Epilepsy Curr, 2010,10(2):47\u201349","journal-title":"Epilepsy Curr"},{"issue":"4","key":"1496_CR34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1460-9568.2001.01428.x","volume":"13","author":"JA Gorter","year":"2001","unstructured":"Gorter JA, van Vliet EA, Aronica E, et al. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci, 2001,13(4):657\u2013669","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1496_CR35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1074\/jbc.275.1.451","volume":"275","author":"YJ Son","year":"2000","unstructured":"Son YJ, Scranton TW, Sunderland WJ, et al. The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface. J Biol Chem, 2000,275(1):451\u2013460","journal-title":"J Biol Chem"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-015-1496-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1496-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T19:50:18Z","timestamp":1567281018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-015-1496-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s11596-015-1496-0","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}